Macrophage physiological function after superparamagnetic iron oxide labeling

NMR in Biomedicine

Volumn 21, Issue 8, 2008, Pages 820-829

  Hsiao, Jong Kai ^a,b   Chu, Hung Hao ^b   Wang, Yu Hsiu ^a   Lai, Chih Wei ^a   Chou, Pi Tai ^a   Hsieh, Sung Tsang ^a,b   Wang, Jaw Lin ^a   Liu, Hon Man ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cytokine; Iron oxide; Migration; Phagocytosis; Proliferation; Rumor necrosis factor; Viability

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; CELL MEMBRANES; CONCENTRATION (PROCESS); CYTOLOGY; LABELING; MACROPHAGES; NITRIC OXIDE; OXIDES; PHYSIOLOGICAL MODELS; SUPERPARAMAGNETISM;

CYTOKINE; IRON OXIDE; MIGRATION; PHAGOCYTOSIS; PROLIFERATION; RUMOR NECROSIS FACTOR; VIABILITY;

IRON OXIDES;

FERUCARBOTRAN; IRON; NANOPARTICLE; NITRIC OXIDE; SUPERPARAMAGNETIC IRON OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BIOACCUMULATION; CELL LABELING; CELL PROLIFERATION; CELL SECRETION; CELL STRUCTURE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMORAL IMMUNITY; INTRACELLULAR TRANSPORT; MACROPHAGE FUNCTION; MACROPHAGE MIGRATION; MEMBRANE STRUCTURE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANIMALS; CELL LINE; CELL PROLIFERATION; CELL SIZE; CELL SURVIVAL; CONTRAST MEDIA; FERRIC COMPOUNDS; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MAGNETICS; MICE; PHAGOCYTOSIS; STAINING AND LABELING;

MURINAE;

EID: 53849117141     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1260     Document Type: Article

References (35)

1. Reimer P, Balzer T. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur. Radiol. 2003; 13: 1266-1276.
2. Catherine CB, Adam SGC. Functionalisation of magnetic nanoparticles for applications in biomedicine. J. Phys. D: Appl. Phys. 2003; 36: R198.
3. Bremer C, Allkemper T, Baermig J, Reimer P. RES-specific imaging of the liver and spleen with iron oxide particles designed for blood pool MR-angiography. J. Magn. Reson. Imaging 1999; 10: 461-467.
4. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science 2006; 311: 622-627.
5. Arbab AS, Yocum GT, Rad AM, Khakoo AY, Fellowes V, Read EJ, Frank JA. Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed. 2005; 18: 553-559.
6. Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, Read EJ, Frank JA. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004; 104: 1217-1223.
7. Pawelczyk E, Arbab AS, Pandit S, Hu E, Frank JA. Expression of transferrin receptor and ferritin following ferumoxides-protamine sulfate labeling of cells: implications for cellular magnetic resonance imaging. NMR Biomed. 2006; 19: 581-592.
8. Cai W, Shin DW, Chen K, Gheysens O, Cao Q, Wang SX, Gambhir SS, Chen X. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett. 2006; 6: 669-676.
9. Moghimi SM, Hunter AC, Murray JC. Nanomedicine: current status and future prospects. FASEB J. 2005; 19: 311-330.
10. Muller J, Huaux F, Moreau N, Misson P, Heilier J-F, Delos M, Arras M, Fonseca A, Nagy JB, Lison D. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol. Appl. Pharmacol. 2005; 207: 221-231.
11. Pestka S, Langer JA, Zoon KC, Samuel CE. Interferons and their actions. Annu. Rev. Biochem. 1987; 56: 727-777.
12. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
13. Bosca L, Zeini M, Traves PG, Hortelano S. Nitric oxide and cell viability in inflammatory cells: a role for NO in macrophage function and fate. Toxicology 2005; 208: 249-258.
14. Nathan C, Shiloh MU. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA 2000; 97: 8841-8848.
15. Metz S, Bonaterra G, Rudelius M, Settles M, Rummeny EJ, Daldrup-Link HE. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur. Radiol. 2004; 14: 1851-1858.
16. Siglienti I, Bendszus M, Kleinschnitz C, Stoll G. Cytokine profile of iron-laden macrophages: implications for cellular magnetic resonance imaging. J. Neuroimmunol 2006; 173: 166-173.
17. Oude Engberink RD, van der Pol SMA, Dopp EA, de Vries HE, Blezer ELA. Comparison of SPIO and USPIO for in vitro Labeling of human monocytes: MR detection and cell function. Radiology 2007; 243: 467-474.
18. Raynal I, Prigent P, Peyramaure S, Najid A, Rebuzzi C, Corot C. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol. 2004; 39: 56-63.
19. Hsiao JK, Tai MF, Chu HH, Chen ST, Li H, Lai DM, Hsieh ST, Wang JL, Liu HM. Magnetic nanoparticle labeling of mesenchymal stem cells without transfection agent: cellular behavior and capability of detection with clinical 1.5 T magnetic resonance at the single cell level. Magn. Reson. Med. 2007; 58: 717-724.
20. Daldrup-Link HE, Rudelius M, Oostendorp RAJ, Settles M, Piontek G, Metz S, Rosenbrock H, Keller U, Heinzmann U, Rummeny EJ, Schlegel J, Link TM. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology 2003; 228: 760-767.
21. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983; 65: 55-63.
22. Kotani N, Hashimoto H, Sessler DI, Kikuchi A, Suzuki A, Takahashi S, Muraoka M, Matsuki A. Intraoperative modulation of alveolar macrophage function during isoflurane and propofol anesthesia. Anesthesiology 1998; 89: 1125-1132.
23. Chen JJW, Lin YC, Yao PL, Yuan A, Chen HY, Shun CT, Tsai MF, Chen CH, Yang PC. Tumor-associated macrophages: the double-edged sword in cancer progression. J. Clin. Oncol. 2005; 23: 953-964.
24. Chang Y, Chen TL, Sheu JR, Chen RM. Suppressive effects of ketamine on macrophage functions. Toxicol. Appl. Pharmacol. 2005; 204: 27-35.
25. 15N] nitrate in biological fluids. Anal. Biochem. 1982; 126: 131-138.
26. Chnari E, Nikitczuk JS, Uhrich KE, Moghe PV. Nanoscale anionic macromolecules can inhibit cellular uptake of differentially oxidized LDL. Biomacromolecules 2006; 7: 597-603.
27. Kagan VE, Tyurina YY, Tyurin VA, Konduru NV, Potapovich AI, Osipov AN, Kisin ER, Schwegler-Berry D, Mercer R, Castranova V, Shvedova AA. Direct and indirect effects of single walled carbon nanotubes on RAW 264.7 macrophages: role of iron. Toxicol. Lett. 2006; 165: 88-100.
28. Hsiao JK, Tai MF, Yang CY, Chen S-T, Wang JL, Ku HC, Liu HM. Comparison of micrometer and nanometer sized magnetic particles for cell labeling. IEEE Trans. Magn. 2007; 43: 2421-2423.
29. Stout RD, Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J. Leukoc Biol. 2004; 76: 509-513.
30. Brillet PY, Clément O, Bessoud B, Luciani A, Siauve N, Cuénod CA. Use of two superparamagnetic iron oxide particles (SPIO) for tumoral imaging: in vitro and in vivo studies. Eur. Radiol. 2003; 13 (Suppl 1): 439.
31. Gupta AK, Gupta M. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials 2005; 26: 1565-1573.
32. Tracey KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Nguyen HT, Kuo GC, Beutler B, Cotran RS, Cerami A. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J. Exp. Med. 1988; 167: 1211-1227.
33. Beutler B, Cerami A. Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response. Endocr. Rev. 1988; 9: 57-66.
34. Arbab AS, Wilson LB, Ashari P, Jordan EK, Lewis BK, Frank JA. A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging. NMR Biomed. 2005; 18: 383-389.
35. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 2004; 17: 484-499.